BioSig Technologies, Inc. STEX EPS (Diluted)
Discontinued — last reported Q1 '26
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s EPS (diluted)?
- BioSig Technologies, Inc. (STEX) reported EPS (diluted) of -$0.27 in Q1 2026.
- How has BioSig Technologies, Inc.'s EPS (diluted) changed year-over-year?
- BioSig Technologies, Inc.'s EPS (diluted) decreased by 92.9% year-over-year, from -$0.14 to -$0.27.
- What is the long-term trend for BioSig Technologies, Inc.'s EPS (diluted)?
- Over 2 years (2023 to 2025), BioSig Technologies, Inc.'s EPS (diluted) has grown at a 54.8% compound annual growth rate (CAGR), from -$4.00 to -$9.58.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.